Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06280677
Status:
RECRUITING
Last Update Posted:
2024-02-28
First Post:
2024-01-31
Brief Title:
Aurora Test for ART Donor Patients AURORA-Donor
Sponsor:
Fertiga Belgium
Organization:
Fertiga Belgium
Study Overview
Official Title:
An Observational Study to Evaluate the Expression Profiles of Oocyte-potency-related Genes in Cumulus Cells of Women Treated With Human Recombinant FSH Hr-FSHand Triggered With GnRH Agonist in an Oocyte Donation Program
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a randomized observational study The main aim is to determine potential oocyte competence predictive mRNA expression profiles in the cumulus cells isolated form individual oocytes In 2 patient cohorts 1GnRH Antagonist hr-FSH with GnRH Agonist trigger 2 Progesterone hr-FSH with GnRH Agonist trigger
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None